Randomized controlled trials, despite their flaws, remain a powerful tool.
No comments yet. Be the first to comment!
Users invited can see your content
- Bloomberg.com (2018)
- CNBC (2018)
- Stanford Graduate School of Business (2018)
(2018)
- TechCrunch (2018)
- D (2018)
- Vox (2018)
(2021)
- The Economist (2023)
- Andreessen Horowitz (2023)
- Claire Hughes Johnson (2023)
- Eric Ries (2023)
- Kim Scott (2023)
- Jessica Livingston (2023)
- Indie Hackers (2023)
- Andreessen Horowitz (2022)
Related chunks with this resource
No comments yet. Be the first to comment!